CVE-2025-45890
Xxyopen Novel-plus remote code execution
- Published20 Jun 2025
Description
Directory Traversal vulnerability in novel plus before v.5.1.0 allows a remote attacker to execute arbitrary code via the filePath parameter
CVSS 3.1 breakdown
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:HAffected products
Remediation
Related CVEs
Recent high-severity vulnerabilities sharing a weakness type.
Frequently asked
Is CVE-2025-45890 being actively exploited?
CVE-2025-45890 is not in the CISA KEV catalog. A public exploit reference exists, so treat it as exploitable. Its EPSS exploit probability is 1.56%.
How severe is CVE-2025-45890?
CVE-2025-45890 has a CVSS 3.1 base score of 9.8, rated critical. EPSS estimates a 1.56% probability of exploitation.
Which products are affected by CVE-2025-45890?
Affected products include Xxyopen Novel-plus.
How do I fix CVE-2025-45890?
Upgrade affected software to a fixed version, for example Xxyopen Novel-plus 5.1.0 or later, then confirm no affected versions remain in your inventory.
How Secuno handles this
Secuno correlates vulnerabilities like CVE-2025-45890 against the real software inventory on every managed device, every day. Rather than a static severity, each match is scored in context: exploit availability, EPSS, the asset's exposure, and business criticality decide where it lands in the queue. If an affected version is present anywhere across your portfolio, it surfaces automatically with a prioritised remediation path.
Data from the NVD, CISA KEV catalog and FIRST EPSS. CVSS 3.1 base score shown where available.